![Addition of CD28 enhance CAR NK function in blood and solid tumors – MD Anderson Cancer Center](https://oncodaily.com/pub/uploads/2023/12/5FACBEB8-D388-4C5A-A99D-C9D64572CEAA-e1702154460759.jpeg)
Photo taken from Katy Rezvani/X
Jun 26, 2024, 04:50
Addition of CD28 enhance CAR NK function in blood and solid tumors – MD Anderson Cancer Center
MD Anderson Cancer Center shared a post on X:
“Research led by Dr. Katy Rezvani found that the addition of CD28, a molecule that is normally absent in mature NK cells, can enhance CAR NK function in blood and solid tumors.
Read how this could enhance NK cell therapies here.”
Source: MD Anderson Cancer Center/X
Aug 10, 2024, 19:12